Drug profile · INN
alclometasone dipropionate
ALCLOMETASONE DIPROPIONATE
alclometasone dipropionate (ALCLOMETASONE DIPROPIONATE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — alclometasone dipropionate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
alclometasone dipropionate (ALCLOMETASONE DIPROPIONATE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is alclometasone dipropionate?
alclometasone dipropionate (ALCLOMETASONE DIPROPIONATE) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for alclometasone dipropionate?
ALCLOMETASONE DIPROPIONATE is a marketed brand name for alclometasone dipropionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alclometasone dipropionate?
alclometasone dipropionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.